Prognostic significance of the CaMBr1 antigen on breast carcinoma: Relevance of the type of recognised glycoconjugate
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (15) , 2113-2117
- https://doi.org/10.1016/0959-8049(93)90045-h
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Glycolipids carrying Ley are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1International Journal of Cancer, 1992
- Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factorsInternational Journal of Cancer, 1991
- Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990
- Relationship between Cambrl Expression and Tumor Progression in Small cell Lung CarcinomasTumori Journal, 1989
- Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patientsCancer, 1988
- Internalization of a monoclonal antibody against human breast cancer by immunoelectron microscopyBritish Journal of Cancer, 1987
- Improvement of Tumor Cell Detection Using a Pool of Monoclonal AntibodiesHybridoma, 1986
- Carbohydrate Epitope Defined by an Antitumor Monoclonal Antibody Detected on Glycoproteins and a Glycolipid by ImmunoblottingHybridoma, 1986
- Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2JNCI Journal of the National Cancer Institute, 1985
- Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinomaVirchows Archiv, 1984